Abstract: Provided are multiply functional telodendrimers. The telodendrimers can be used for combination drug delivery. The telodendrimers may have one or more crosslinking groups (e.g., reversible photocrosslinking groups). The telodendrimers can aggregate to form nanocarriers. Cargo such as combinations of drugs, imaging probes, and other materials may be sequestered in the core of the aggregates via non-covalent or covalent interactions with the telodendrimers. Such nanocarriers may be used in drug delivery applications and imaging applications.
Type:
Grant
Filed:
November 5, 2019
Date of Patent:
April 6, 2021
Assignee:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Abstract: The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula (I).
Type:
Grant
Filed:
March 10, 2017
Date of Patent:
April 6, 2021
Assignee:
The Research Foundation for the State University of New York
Inventors:
Iwao Ojima, Dale Deutsch, Martin Kaczocha, Kongzhen Hu, Simon Tong, Matthew Elmes, Su Yan
Abstract: Provided are macrocyclic compounds and iron or cobalt coordinated macrocyclic compounds. The compounds can be used as MRI contrast agents. Certain compounds are redox active and can be used to assess the biological redox status of a sample.
Type:
Grant
Filed:
September 12, 2014
Date of Patent:
March 30, 2021
Assignees:
The Research Foundation for The State University of New York, Health Research, Inc.
Inventors:
Janet R. Morrow, Pavel B. Tsitovich, Sarina J. Dorazio, Abiola O. Olatunde, Joseph A. Spernyak, Patrick Burns, Eric M. Snyder, Christopher J. Bond
Abstract: The invention provides adeno-associated virus (AAV) replication (Rep) sequences. In one embodiment, the invention provides nucleotide sequences encoding a chimeric protein, wherein the encoded chimeric protein contains a wild type AAV Rep inhibitory amino acid sequence, and wherein the nucleotide sequences contain a scrambled and/or deoptimized polynucleotide sequence encoding the wild type AAV Rep inhibitory amino acid sequence. The invention provides vectors, cells, and viruses containing the invention's sequences. Also provided are methods for detecting portions of the AAV Rep inhibitory amino acid sequence, which reduce replication and/or infection and/or productive infection by viruses. The invention's compositions and methods are useful for site-specific integration and/or expression of heterologous sequences by recombinant adeno-associated virus (rAAV) vectors and by rAAV virus particles, such as hybrid viruses (e.g., Ad-AAV) comprising such vectors.
Type:
Grant
Filed:
January 23, 2019
Date of Patent:
March 16, 2021
Assignee:
The Research Foundation For The State University Of New York
Inventors:
Wadie F. Bahou, Patrick Hearing, Varsha Sitaraman
Abstract: Disclosed herein are methods of treatment for an intraocular pressure (IOP)-associated condition in a subject, that include administering to the subject an effective amount of a tissue plasminogen activator (tPA) therapeutic agent. In one embodiment, the IOP-associated condition is glaucoma. The administration of a tPA therapeutic agent can be an extended administration intended to cause a reduction in IOP in the subject for a period of at least one day to a year or more, relative to IOP levels in the subject prior to administration of the tPA therapeutic agent. The tPA therapeutic agent can be, for example, tPA, a tPA derivative, a small molecule direct or indirect tPA agonist, or a gene therapy vector.
Type:
Grant
Filed:
February 12, 2014
Date of Patent:
March 16, 2021
Assignees:
The Research Foundation for The State University of New York, Icahn School of Medicine at Mount Sinai
Inventors:
Ioannis Danias, Oscar A. Candia, Rosana Gerometta
Abstract: Provided are multiply functional charged telodendrimers. The telodendrimers can be used for protein encapsulation and delivery. The charged telodendrimers may have one or more crosslinking groups (e.g., boronic acid/catechol reversible crosslinking groups). The telodendrimers can aggregate to form nanoparticles. Cargo such as combinations of proteins and other materials may be sequestered in the core of the nanoparticles via non-covalent or covalent interactions with the telodendrimers. Such nanoparticles may be used in protein delivery applications.
Type:
Grant
Filed:
September 12, 2016
Date of Patent:
March 16, 2021
Assignee:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Abstract: The present disclosure is directed to films. The films can include polyamic acid (PAA). Methods of making and using the film for food product coverings is also included.
Type:
Application
Filed:
September 30, 2020
Publication date:
March 4, 2021
Applicant:
The Research Foundation for The State University of New York
Abstract: Structures operable to detect radiation are described. An imaging system is also described having the structures. For example, a structure may include two screens and a photosensor array between the two screens. One of the screens is comprised of a scintillating glass substrate. The scintillating glass substrate may serve two purposes. The scintillating glass substrate converts incident x-rays into light photons. Additionally, the scintillating glass substrate is a substrate for the photosensor array. The photosensor array is configured to detect light photons that reach the photosensor array from both screens.
Type:
Application
Filed:
May 23, 2019
Publication date:
March 4, 2021
Applicant:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Anthony LUBINSKY, Adrian HOWANSKY, Wei ZHAO
Abstract: An HVAC register airflow control system and an air flow control method are provided. A housing of the system is in fluid communication with an air source for supplying an airflow. The housing includes an air outlet to the enclosed space. A detection sensor detects occupancy information of the enclosed space. A controller generates a control signal based on the occupancy information and controls the shape change of a damper made of a shape memory material. The damper is controlled to switch between a first operative configuration for preventing the airflow from entering the enclosed space and a second operative configured for permitting the airflow to enter the enclosed space.
Type:
Grant
Filed:
April 10, 2018
Date of Patent:
March 2, 2021
Assignee:
The Research Foundation for The State University of New York
Abstract: This invention provides a compound having the structure wherein ?, ?, X, Y, and R1-R11 are defined herein. This invention also provides a pharmaceutical composition comprising the above compounds, a method of inhibiting the activity and/or levels of a matrix metalloproteinase (MMP), a method of inhibiting the production of a cytokine in a population of cells, a method of inhibiting the production of a growth factor in a population of cells, and a method of inhibiting NF?-B activation in a population of cells.
Type:
Application
Filed:
May 28, 2020
Publication date:
February 25, 2021
Applicants:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, CHEM-MASTER INTERNATIONAL, INC.
Abstract: The present disclosure provides a fluoroscopic needle guide device for use in medical procedures that facilitate the direct targeting of a pre-identified target in a subject and methods for reaching the same with a medical device. The present disclosure includes fluoroscopic needle guide devices including detachable alignment indicators and methods for using the same.
Type:
Grant
Filed:
May 12, 2016
Date of Patent:
February 23, 2021
Assignee:
The Research Foundation for The State University of New York
Inventors:
Christopher Page, Anurag Purwar, Pranav Korrapati
Abstract: This disclosure relates to systems and methods to analyze gait, balance or posture information extracted from data collected by one or more wearable and connected sensor devices with sensors embedded therewithin. The embedded sensors include a three-axis accelerometer, a three-axis gyroscope and an array of pressure sensors. Sensor data detected by the sensors can be received by a mobile computing device, which can analyze the sensor data to identify a pattern related to gait, balance or posture within the sensor data; and apply a statistical/machine learning-based classification to the pattern related to gait, balance or posture to assign a clinical parameter to the pattern characterizing a risk of a slip, trip and fall event.
Type:
Grant
Filed:
September 28, 2016
Date of Patent:
February 16, 2021
Assignees:
CASE WESTERN RESERVE UNIVERSITY, THE RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK
Abstract: A reconfigurable free-space optical inter-rack network includes a plurality of server racks, each including at least one switch mounted on a top thereof, where each top-mounted switch includes a plurality of free-space-optic link connector, each with a free-space optical connection to a free-space-optic link connector on another top-mounted switch, a single ceiling mirror above the plurality of server racks that substantially covers the plurality of server racks, wherein the single ceiling mirror redirects optical connections between pairs of free-space-optic link connectors to provide a clear lines-of-sight between each pair of connected free-space-optic link connectors, and a controller that preconfigures a free-space optical network connecting the plurality of server racks by establishing connections between pairs of free-space-optic link connectors, and that reconfigures connections between pairs of free-space-optic link connectors in response to network traffic demands and events.
Type:
Grant
Filed:
June 15, 2018
Date of Patent:
February 16, 2021
Assignee:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Himanshu Gupta, Navid Hamedazimi, Samir Ranjan Das, Jon Longtin, Vyas Sekar, Max Curran
Abstract: Provided are serum-stable nanoparticles comprising porphyrin-phospholipid conjugates. Also provided are compositions comprising the nano-particles. The nanoparticles can comprise cargo such as therapeutic agents and/or diagnostic agents (e.g., imaging agents) and be used in drug delivery methods based on NIR stimulated cargo release.
Type:
Grant
Filed:
April 4, 2016
Date of Patent:
February 16, 2021
Assignee:
The Research Foundation for The State University of New York
Inventors:
Jonathan Lovell, Dandan Luo, Kevin Carter, Shuai Shao, Jumin Geng
Abstract: One aspect of the invention relates to an adaptor for use in a surgical retractor system including a surgical retractor bar having a longitudinal extent between a first end and a second end and a self-retaining retractor device with arms moveable between spaced and proximate positions. The adaptor includes a first plate coupled to a second plate, optionally by one or more connecting elements. A slot is formed between the first plate and the second plate and is configured to either longitudinally receive either the first end or the second end of the surgical retractor bar or laterally receive a lateral edge of the surgical retractor bar such that the adaptor is positioned along the longitudinal extent between the first end and the second end of the surgical retractor bar during use. One or more retaining elements are located on a first surface of the first plate opposite the slot between the first plate and the second plate.
Type:
Grant
Filed:
December 19, 2018
Date of Patent:
February 9, 2021
Assignee:
The Research Foundation for The State University of New York
Abstract: The present invention provides a compound having the structure: a processing of making the compound; and a process of using the compound as a reagent for the difluoromethoxylation and trifluoromethoxylation of arenes or heteroarenes.
Type:
Application
Filed:
February 26, 2019
Publication date:
February 4, 2021
Applicant:
The Research Foundation for the State University of New York
Abstract: Synthetic disaccharide hydrocarbons (DSHs) that reactive bacterials swarming motility and inhibit bacterial adhesion and biofilm formation. A library of DSHs were tested in several experiment for the impact on various Pseudomonas aeruginosa populations and compared against existing compounds to determine efficacy and utility. Certain DSHs were also to determine the ability to clear bacteria in a mouse pneumonia model.
Type:
Application
Filed:
October 2, 2020
Publication date:
January 28, 2021
Applicants:
Syracuse University, The Research Foundation for the State University of New York
Abstract: Devices, systems, and methods for ambient-temperature quantum information buffering, storage, and communication are provided enabling receiving a quantum communication (for example, photons holding quantum information, e.g., qubits), storing the qubits in a room-temperature scalable quantum memory device, selectively retrieving the qubits, performing filtering, and extracting the quantum communication with a controllable delay.
Type:
Application
Filed:
March 28, 2019
Publication date:
January 28, 2021
Applicant:
The Research Foundation for The State University of New York
Inventors:
Eden Figueroa, Mehdi Namazi, Mael Flament
Abstract: Methods and devices for transmitting and receiving data through biological tissue using ultrasonic pulses are described. Methods of the present invention may set an initial time-hopping frame length and an initial spreading code length for data transmission. A request-to-transmit may be sent from a transmitter over a control channel at the initial frame and code length. The receiver may respond to the transmitter with a clear-to-transmit packet having feedback information. The feedback information can be used to improve a forward time-hopping frame length and a forward spreading code length. Embodiments of the invention may involve a body area network or body surface network comprising a plurality of implanted sensor nodes operating according to the disclosed invention.
Type:
Grant
Filed:
September 30, 2014
Date of Patent:
January 26, 2021
Assignee:
The Research Foundation for The State University of New York
Inventors:
Tommaso Melodia, Giuseppe Enrico Santagati, Laura Galluccio, Sergio Palazzo
Abstract: A sensor including a layer of amorphous selenium (a-Se) and at least one charge blocking layer is formed by depositing the charge blocking layer over a substrate prior to depositing the amorphous selenium, enabling the charge blocking layer to be formed at elevated temperatures. Such a process is not limited by the crystallization temperature of a-Se, resulting in the formation of an efficient charge blocking layer, which enables improved signal amplification of the resulting device. The sensor can be fabricated by forming first and second amorphous selenium layers over separate substrates, and then fusing the a-Se layers at a relatively low temperature.
Type:
Grant
Filed:
July 28, 2020
Date of Patent:
January 26, 2021
Assignee:
The Research Foundation for The State University of New York